Universal Updated Phase 1 Data Highlights Role of Allogeneic Anti-BCMA ALLO-715 Therapy for Relapsed/Refractory Multiple Myeloma Mailankody, S., Matous, J., Liedtke, M., Sidana, S., Oluwole, O. O., Mohan, M., Cruz, J. C., Nath, R., Anwer, F., Rossi, A., Htut, M., Malik, S. A., Ghatta, S., Dillon, M., Ying, W., Navale, L., Karski, E. E., Balakumaran, A., Kumar, S. K. AMER SOC HEMATOLOGY. 2022: 4620-4622

View details for DOI 10.1182/blood-2022-158231

View details for Web of Science ID 000893223204284